CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...